Suppression of neuropathic pain and comorbidities by recurrent cycles of repetitive transcranial direct current motor cortex stimulation in mice.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 05 2021
Historique:
received: 23 12 2020
accepted: 12 03 2021
entrez: 7 5 2021
pubmed: 8 5 2021
medline: 3 11 2021
Statut: epublish

Résumé

Transcranial, minimally-invasive stimulation of the primary motor cortex (M1) has recently emerged to show promise in treating clinically refractory neuropathic pain. However, there is a major need for improving efficacy, reducing variability and understanding mechanisms. Rodent models hold promise in helping to overcome these obstacles. However, there still remains a major divide between clinical and preclinical studies with respect to stimulation programs, analysis of pain as a multidimensional sensory-affective-motivational state and lack of focus on chronic phases of established pain. Here, we employed direct transcranial M1 stimulation (M1 tDCS) either as a single 5-day block or recurring blocks of repetitive stimulation over early or chronic phases of peripherally-induced neuropathic pain in mice. We report that repeated blocks of stimulation reverse established neuropathic mechanical allodynia more strongly than a single 5-day regime and also suppress cold allodynia, aversive behavior and anxiety without adversely affecting motor function over a long period. Activity mapping revealed highly selective alterations in the posterior insula, periaqueductal gray subdivisions and superficial spinal laminae in reversal of mechanical allodynia. Our preclinical data reveal multimodal analgesia and improvement in quality of life by multiple blocks of M1 tDCS and uncover underlying brain networks, thus helping promote clinical translation.

Identifiants

pubmed: 33958647
doi: 10.1038/s41598-021-89122-6
pii: 10.1038/s41598-021-89122-6
pmc: PMC8102487
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9735

Références

Neural Plast. 2016;2016:3898924
pubmed: 27833762
Behav Brain Funct. 2019 Mar 25;15(1):5
pubmed: 30909927
Neuroimage. 2007;37 Suppl 1:S71-9
pubmed: 17644413
eNeuro. 2017 Mar 29;4(2):
pubmed: 28374016
J Physiol. 2000 Sep 15;527 Pt 3:633-9
pubmed: 10990547
Annu Rev Pharmacol Toxicol. 1980;20:441-62
pubmed: 7387124
Behav Brain Res. 2009 Aug 24;202(1):138-41
pubmed: 19447290
Neurosci Lett. 2018 Sep 25;684:145-151
pubmed: 30056105
Pain. 2015 Jun;156(6):1060-1073
pubmed: 25760470
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Cell. 2016 Jun 16;165(7):1789-1802
pubmed: 27238021
Nat Neurosci. 2019 Sep;22(9):1424-1437
pubmed: 31455886
Somatosens Res. 1988;5(3):259-67
pubmed: 3358044
J Pain Manag. 2009 Aug;2(3):339-352
pubmed: 20585474
Eur J Neurol. 2016 Oct;23(10):1489-99
pubmed: 27511815
Behav Brain Res. 2013 Aug 1;250:211-21
pubmed: 23692698
Nat Neurosci. 2015 Apr;18(4):499-500
pubmed: 25751532
Brain Res. 2018 Mar 1;1682:14-23
pubmed: 29274881
Physiol Rev. 2021 Jan 1;101(1):213-258
pubmed: 32525759
Physiol Rev. 2021 Jan 1;101(1):259-301
pubmed: 32584191
Pharmacol Biochem Behav. 1994 Oct;49(2):263-9
pubmed: 7824536
J Vis Exp. 2018 Sep 23;(139):
pubmed: 30295664
J Neurosci. 2014 Jan 8;34(2):346-55
pubmed: 24403136
Pain. 2012 Dec;153(12):2359-2369
pubmed: 23017297
Nat Rev Neurosci. 2016 Dec 15;18(1):20-30
pubmed: 27974843
Nat Protoc. 2007;2(2):322-8
pubmed: 17406592
J Neurosci. 2018 May 16;38(20):4829-4839
pubmed: 29695413
Eur J Neurosci. 2014 Jun;39(11):1881-90
pubmed: 24888508
Physiol Res. 2019 Dec 20;68(Suppl 3):S353-S359
pubmed: 31928053
Nat Neurosci. 2019 Oct;22(10):1659-1668
pubmed: 31501573
PLoS One. 2019 Aug 15;14(8):e0221110
pubmed: 31415654
Pain. 2013 Dec;154 Suppl 1:S29-S43
pubmed: 24021862
Clin Neurophysiol. 2020 Feb;131(2):474-528
pubmed: 31901449
World Neurosurg. 2018 Jun;114:e800-e808
pubmed: 29572175
Neuropsychopharmacology. 2004 Jun;29(6):1172-89
pubmed: 15029151
Pain. 2000 Aug;87(2):149-158
pubmed: 10924808
Psychopharmacology (Berl). 2020 Feb;237(2):345-361
pubmed: 31646346
PLoS One. 2016 Apr 12;11(4):e0153506
pubmed: 27071073
Nat Rev Neurosci. 2005 Jul;6(7):533-44
pubmed: 15995724
Sci Rep. 2019 Jul 1;9(1):9479
pubmed: 31263213
J Neurosurg. 2016 Mar;124(3):866-76
pubmed: 26274988
Lancet Neurol. 2014 Sep;13(9):924-35
pubmed: 25142459
Clin Neurophysiol. 2014 Nov;125(11):2150-2206
pubmed: 25034472
J Vis Exp. 2015 Feb 06;(96):e52434
pubmed: 25742564
Sci Rep. 2016 Feb 24;6:22180
pubmed: 26908001
Restor Neurol Neurosci. 2010;28(4):477-84
pubmed: 20714072
Nat Commun. 2019 Feb 28;10(1):983
pubmed: 30816113
Sci Rep. 2017 Aug 11;7(1):7986
pubmed: 28801619
Neurobiol Dis. 2020 Jul;140:104862
pubmed: 32251841
Brain Stimul. 2016 Mar-Apr;9(2):209-17
pubmed: 26775175
Nat Rev Neurosci. 2016 Aug;17(8):485-96
pubmed: 27307118
Nat Rev Neurol. 2011 Sep 20;7(12):699-709
pubmed: 21931348
CNS Neurosci Ther. 2016 Feb;22(2):146-53
pubmed: 26663888
Neuroimage. 2007 Jan 1;34(1):310-21
pubmed: 17055297
Lab Anim. 2016 Jun;50(3):212-6
pubmed: 26442519
Pain. 2018 Nov;159(11):2339-2346
pubmed: 30015707
BMC Neurol. 2019 Oct 15;19(1):237
pubmed: 31615444
Neuropharmacology. 2014 Sep;84:123-30
pubmed: 23891639
Mol Brain. 2014 Oct 04;7:72
pubmed: 25277376
BMJ. 2014 Feb 05;348:f7656
pubmed: 24500412
Brain Res. 2013 Jul 26;1523:59-67
pubmed: 23726994
Pain. 2016 Mar;157(3):687-697
pubmed: 26588690
Mol Psychiatry. 2016 Oct;21(10):1408-16
pubmed: 26666202
Eur J Pain. 2011 Mar;15(3):268.e1-14
pubmed: 20817578
Nat Neurosci. 2017 Nov;20(11):1591-1601
pubmed: 28920932
J Neurosurg. 2019 Jan 4;132(1):239-251
pubmed: 30611141
Brain Stimul. 2008 Oct;1(4):337-44
pubmed: 20633392
Neuron. 2015 Jan 21;85(2):377-89
pubmed: 25556835
Methods Enzymol. 2018;603:197-220
pubmed: 29673526

Auteurs

Zheng Gan (Z)

Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.

Han Li (H)

Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.

Paul Vincent Naser (PV)

Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.

Manfred Josef Oswald (MJ)

Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.

Rohini Kuner (R)

Institute of Pharmacology, Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany. rohini.kuner@pharma.uni-heidelberg.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH